Literature DB >> 21969092

Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome.

Patricia G Vallés1, Silvia Melechuck, Adriana González, Walter Manucha, Victoria Bocanegra, Roberto Vallés.   

Abstract

Lipopolysaccharide stimulation of toll-like receptor 4 (TLR4) activates signal transduction pathways leading to proinflammatory cytokine secretion. We investigated TLR4 surface receptor expression on peripheral blood neutrophils and monocytes and their ability to modulate inflammatory cytokine release in 15 patients 1, 3, and 10 days after hemolytic uremic syndrome (HUS) onset. Seven patients with Escherichia coli (EHEC)-associated diarrhea and seven healthy controls were also studied. Isolated leucocytes from HUS-onset patients exhibited significantly higher messenger RNA (mRNA) TLR4 expression than controls. Moreover, TLR4 protein expression on neutrophils, determined by flow cytometry, was upregulated, driving dependent proinflammatory cytokine, tumor necrosis factor alpha (TNF-α), and interleukin 8 (IL-8) increase, and decreased anti-inflammatory IL-10 release at HUS onset compared with patients with EHEC diarrhea and controls. TLR4 expression on neutrophils was positively correlated with serum TNF-α levels. Conversely, significant reduction of neutrophil TLR4 receptor expression and lack of cytokine-responsive element activation was shown in patients 3 and 10 days after HUS onset. No differences were demonstrated in TLR4 receptor expression on monocytes among the studied groups. Our results suggest TLR4 expression may be differently regulated on neutrophils and monocytes. They could be dynamically modulated across the early development of HUS on neutrophils, resulting in negative regulation preceded by TLR4 overactivation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969092     DOI: 10.1007/s00467-011-2014-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  39 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome.

Authors:  Gabriela C Fernández; María V Ramos; Sonia A Gómez; Graciela I Dran; Ramón Exeni; Marta Alduncín; Irene Grimoldi; Graciela Vallejo; Christian Elías-Costa; Martín A Isturiz; Marina S Palermo
Journal:  J Leukoc Biol       Date:  2005-07-26       Impact factor: 4.962

3.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

4.  Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues.

Authors:  S Westerholt; T Hartung; M Tollens; A Güstrau; M Oberhoffer; H Karch; B Klare; K Pfeffer; P Emmrich; R Oberhoffer
Journal:  Cytokine       Date:  2000-06       Impact factor: 3.861

5.  TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock.

Authors:  Milena Karina Colo Brunialti; Paulo Sergio Martins; Heraclito Barbosa de Carvalho; Flavia Ribeiro Machado; Leandro Martins Barbosa; Reinaldo Salomao
Journal:  Shock       Date:  2006-04       Impact factor: 3.454

6.  The formyl peptide N-formyl-methionyl-leucyl-phenylalanine downregulates the expression of FcgammaRs in interferon-gamma-activated monocytes/macrophages in vitro and in vivo.

Authors:  M Beigier-Bompadre; P Barrionuevo; F Alves-Rosa; C J Rubel; M S Palermo; M A Isturiz
Journal:  Scand J Immunol       Date:  2003-03       Impact factor: 3.487

7.  Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha.

Authors:  Verónica I Landoni; Marcelo de Campos-Nebel; Pablo Schierloh; Cecilia Calatayud; Gabriela C Fernandez; M Victoria Ramos; Bárbara Rearte; Marina S Palermo; Martín A Isturiz
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

8.  Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome.

Authors:  Anne-lie Ståhl; Majlis Svensson; Matthias Mörgelin; Catharina Svanborg; Phillip I Tarr; Jody C Mooney; Sandra L Watkins; Roger Johnson; Diana Karpman
Journal:  Blood       Date:  2006-03-02       Impact factor: 22.113

9.  Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinase- and MAPK-dependent mechanism.

Authors:  Nicolas Sémiramoth; Aude Gleizes; Isabelle Turbica; Catherine Sandré; Roseline Gorges; Imad Kansau; Alain Servin; Sylvie Chollet-Martin
Journal:  J Leukoc Biol       Date:  2008-11-17       Impact factor: 4.962

10.  MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.

Authors:  R Shimazu; S Akashi; H Ogata; Y Nagai; K Fukudome; K Miyake; M Kimoto
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more
  8 in total

Review 1.  Prophylactic vaccinations in chronic kidney disease: Current status.

Authors:  Alicja E Grzegorzewska
Journal:  Hum Vaccin Immunother       Date:  2015-04-27       Impact factor: 3.452

Review 2.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

Review 3.  Mediators and mechanisms of heat shock protein 70 based cytoprotection in obstructive nephropathy.

Authors:  Luciana Mazzei; Neil G Docherty; Walter Manucha
Journal:  Cell Stress Chaperones       Date:  2015-07-31       Impact factor: 3.667

Review 4.  Hemolytic uremic syndrome: toxins, vessels, and inflammation.

Authors:  Victoria Cheung; Howard Trachtman
Journal:  Front Med (Lausanne)       Date:  2014-11-04

5.  Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice.

Authors:  Fumiko Obata; Priyanka B Subrahmanyam; Aimee E Vozenilek; Lauren M Hippler; Tynae Jeffers; Methinee Tongsuk; Irina Tiper; Progyaparamita Saha; Dakshina M Jandhyala; Glynis L Kolling; Olga Latinovic; Tonya J Webb
Journal:  Front Microbiol       Date:  2015-04-08       Impact factor: 5.640

6.  Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.

Authors:  Mariana Luna; Mariana Kamariski; Iliana Principi; Victoria Bocanegra; Patricia G Vallés
Journal:  Pediatr Nephrol       Date:  2020-11-17       Impact factor: 3.714

Review 7.  Acute kidney injury: what part do toll-like receptors play?

Authors:  Patricia G Vallés; Andrea Gil Lorenzo; Victoria Bocanegra; Roberto Vallés
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-06-19

8.  Basic inflammatory indices and chosen neutrophil receptors expression in chronic haemodialysed patients.

Authors:  Zbigniew Baj; Zbigniew Zbróg; Adam Szuflet; Sylwia Mańka; Piotr Bartnicki; Ewa Majewska
Journal:  Cent Eur J Immunol       Date:  2018-06-30       Impact factor: 2.085

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.